SIGA trade ideas
Maintains Strong Growth Amid Global Health FocusSIGA Technologies Posts Q2 2024 Earnings, Maintains Strong Growth Amid Global Health Focus
SIGA Technologies, Inc. (NASDAQ: SIGA) reported solid financial results for Q2 2024. The company posted revenue of $21.81 million, largely driven by sales of its flagship product, TPOXX®, an antiviral medication used for smallpox and mpox (monkeypox). Earnings per share (EPS) came in at $0.03, exceeding analyst expectations.
Financial and Market Performance
• Revenue: $21.81 million, showing steady product sales.
• EPS: $0.03, beating forecasts.
• Stock Performance: The stock is trading around $10.13, up significantly year-to-date, with a strong P/E ratio of 9.49 .
Future Outlook
Analysts forecast earnings growth of 23.76% over the next year, with EPS expected to rise to $1.25 in 2025. SIGA’s focus on infectious disease treatments and government contracts positions it well for continued growth.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
SIGA - 2000% pumpIn March 2022, the stock of SIGA Technologies saw a significant increase due to growing concerns about the monkeypox outbreak. The primary driver of this growth was the World Health Organization (WHO) declaring the monkeypox outbreak a global health emergency. This attracted investors' attention to the company, as its main product, the antiviral drug Tecovirimat (TPOXX), was developed to treat smallpox and has proven effective against monkeypox.
SIGA Technologies Analysis 6/24Disclosure: As of 6/24 I am long SIGA Technologies NASDAQ:SIGA
SIGA Technologies is a bio pharmaceuticals company that is in the public health market. They develop and sell products to treat Smallpox, Ebola, and other public health threats.
Management Effectiveness: The company has been consistently profitable since 2018, with margins averaging 30%-40% in recent years with only a few unprofitable quarters.
Very quickly after the company became profitable they brought the debt to essentially nothing.
In recent years the company's return on equity has been above 25%, indicating their research spending is used effectively.
The company has a large cash position for potential investment in research.
Valuation The company trade at a P/E of 6 and a p/cf of 8 they have paid special dividends for several years and could potentially implement a stock buyback program, at least that is something I would be considering if I were a board member (Disclosure: I am not a board member obviously).
Summary NASDAQ:SIGA is a well run company, trading at an excellent valuation if you are willing to take the risk of a concentrated portfolio of products and volatile returns. They have several positive tailwinds including: International Expansion, Re-Valuation of the company due to implementation of a dividend or buyback policy, and increased public health awareness by international governments.
SIGA Technologies Options Ahead of EarningsAnalyzing the options chain and the chart patterns of SIGA Technologies prior to the earnings report this week,
I would consider purchasing the 5usd strike price Calls with
an expiration date of 2024-6-21,
for a premium of approximately $0.50.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
SIGA a Biotech breakout last summer- then breakdown ? reversalAs shown on the daily chart dating back to last summer SIGA has been on a persistent decline since the cooling down from the parabolic
breakout last summer. Is there a repeat in the picture? Fundamentally, earnings continue to be weak. much of the stock is held by insiders and
the whole monkey pox thing is settled down although the main product may have use in malaria, leper's disease or whatever other orphan use
it has indications by the FDA and its foreign counterparts.
The technical picture is that it is sitting just above support shown by the Supply Demand Zone indicator of Luxalgo having double bottomed
and now a bit above it. The volume indicator shows a mild increase in buying volume in the past couple of weeks. Price is more than one
standard deviation below the long-term anchored VWAP in the undervalued over-sold zone.
With a weak biotechnology company where insiders have a fair portion of the shares, manipulation can occur. Once a price rise issues
short sellers will buy to cover, and retail traders will jump on board, insiders will "manufacture" a catalyst to prime the pump further.
At some point, the run-up will stall, and the implode itself. I will get on the ride early, a biotechnology speculative trades are
in my playbook. The stop loss here is below the demand zone while the target is the 50% retracement of the downtrend drawn onto
the chart by the Fibonacci Retracement tool.
$SIGA perfect example of Bump and Run bearish pattern$SIGA followed my chart very precisely and hit my short target💪
I just noticed that $SIGA actually forming a Bump and Run bearish pattern and it could dip even lower to $8-8.60
If it holds above the trendline and volume increases, this pattern may be invalid...
SIGA IMPULSE DOWN INTO BIG BIG LEVELVery interesting level here for SIGA.
Not rushing into anything but if we can get this yellow level to hold as support and push higher. Could be a great long term entry.
Massive move down with no relief on the way down at all. With a massive level like this it could be a great opportunity for a swing
SIgA Large rising broadening wedge. Last discussion was talking about SIgA topping out in the 23.59 area. Now look what has happened since then We have dropped back to lower support. This is where we get greedy and load the boat with stops below 13.50. Try to get in closer to 14s if this holds we should see price resort to the upper sloping broadening resitance towards 24$
$SIGA Bearish Rising Wedge formation
$SIGA Bearish Rising Wedge formation in the daily TF.
It needs a correction to continue this run, it might test the support level at $16-17 then bounce from there.
** I called $SIGA since it was below $11 (check my previous TAs), so if you followed my TA I guess you made a killing profit 💰
SIGA to Break Upper Trendline?SIGA has an ascending channel pattern on the daily chart.
A closer look at SIGA shows a bull flag formation on the hourly chart.
I strongly believe that a break of the flag (on the hourly) will push SIGA above the upper trendline of the ascending channel (on the daily).
The measured potential maximum move of the bull flag is approximately 4.18 points and the measured potential maximum move of the ascending channel is approximately 15.90 points. Therefore, the combined potential maximum move approximation is 20.08 points.
Therefore, my entry will occur after price breaks and holds level 24.
*This is not financial advice.
Loved and Blessed,
MrALTrades00
Textbook parabolic arcLast weeks short position achieved massive gains when this ticker made a parabolic downside move from 23 to 14, accompanied with two trading halts
Now the chart is showing a textbook parabolic arc pattern. From base 3 to the top of 5 was a 100% gain
Once this breaks structure I feel we will have massive downsized gains
This stock is trading at 30 year highs, Sentiment in public chats seems to be borderline delusional.
Their drug is approved for smallpox with animal testing, smallpox has been eradicated for 40 years.
This is not approved by the fda for monkeypox
The market cap is currently 1.6 billion and their revenues from earnings last week was 15 million
Looks like the perfect storm to me.
SIgA Watching 23.60 area. For me it could turn up as rising resiatnce. I didn’t get to post about my entry yeateday at 17.75. I saw it come up on the news and also the chart looked great. 19.02 is monster support that has to hold up as it has bounce off it. Could this rising reistance reject us? If we closed above the.ln this idea will be invalid but as of now that’s what my expectations are.
SIGA Looking good and looking for moreMost Recent News - finance.yahoo.com
This stock has been on my radar all week and has been a solid slow grinder play for me. I have scaled my positions along the way and have about 20% of my position left. It was a day full of green candles with steady volume going into each of them. The day consisted of SIGA setting higher highs all day with it closing off at its current all time high. I anticipate more moves ahead here especially as more news comes out on Monkeypox and with the earnings report coming out next week as well. Each and every day I am assessing this differently but as I prepare for tomorrow, I am looking to have a S/L around the 21.50 zone to secure remaining profits in case it falls too far down from where it is now. Otherwise I am looking for it to break the $24 tomorrow.